<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="208701">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00371072</url>
  </required_header>
  <id_info>
    <org_study_id>8370</org_study_id>
    <nct_id>NCT00371072</nct_id>
  </id_info>
  <brief_title>Trabeculectomy With MMC Versus Ahmed Glaucoma Implant for Treatment of Pediatric Aphakic Glaucoma</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shahid Beheshti University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shahid Beheshti University of Medical Sciences</source>
  <brief_summary>
    <textblock>
      In this randomized clinical trial we compare trabeculectomy with mitomycin-C (T+MMC) and
      Ahmed glaucoma implant (AGI) in treatment of aphakic glaucoma in children under 16 years of
      age.Complete and qualified success were defined as 5≤IOP≤21mmHg without and with medication
      respectively and we came to this point that; T+MMC and AGI are comparable in terms of
      success rate and complications in pediatric aphakic glaucoma.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2004</start_date>
  <completion_date>November 2005</completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single Blind</masking>
  </study_design_info>
  <condition>Pediatric Aphakic Glaucoma</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>trabeculectomy with mitomycin-C</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  congenital cataract

          -  history of cataract surgery

          -  under 16 years old

          -  Ocular pressure more than 21 mmHg

        Exclusion Criteria:

          -  interruption of the follow up before 6 month

          -  Anterior segment dysgenesis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohammad Pakravan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ophthalmic Research Center of Shaheed Beheshti Medical University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ophthalmic Research Center</name>
      <address>
        <city>Tehran</city>
        <zip>16666</zip>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>July 2003</verification_date>
  <lastchanged_date>October 6, 2006</lastchanged_date>
  <firstreceived_date>August 31, 2006</firstreceived_date>
  <keyword>Aphakic Glaucoma</keyword>
  <keyword>trabeculectomy with mitomycin- C</keyword>
  <keyword>Ahmed glaucoma implant</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Glaucoma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Mitomycin</mesh_term>
    <mesh_term>Mitomycins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
